Home » ocular pharmacokinetics

Iris Pharma is a French Contract Research Organization (CRO) dedicated to preclinical services and clinical trials in ophthalmology and also ocular pharmacokinetics.

Founded in 1989 by Pierre-Paul Elena, Ph.D., Iris Pharma provides ocular pharmacokinetics to Biotechnology and Pharmaceutical Industries.

Ocular pharmacokinetics in animals and humans

In animal models, Iris Pharma studies ocular pharmacokinetics of ocular drug and metabolite.

In Healthy Volunteers (phase I clinical study) Iris Pharma has the capabilities to perform the following types of phase 1 clinical studies: Ocular Tolerance, Safety, Systemic and Ocular Pharmacokinetics - pharmacodynamics (PK/PD) and first administration in human.

Ocular Pharmacokinetics and in-depth research

Iris Pharma provides Ocular Pharmacokinetics and has the following fields of expertise:

• Glaucoma/Ocular hypertension
• Ocular Pharmacokinetics Studies about Dry eye syndrome
• Ocular Pharmacokinetics Studies about Cataract
• Ocular inflammation
• Ocular Pharmacokinetics Studies regarding Ocular allergy
• Ocular infection
• Age-related Macular Degeneration (AMD)
• Diabetic retinopathy
• Contactology
• Medical Services
• Ocular Drug Development